GLP-1 Medications May Reduce Cancer Progression, Study Says (huffpost.com)

• Study demonstrates inhibition of cancer progression by GLP-1 drugs
• Potential changes in Irish treatment guidelines
• Relevance to HSE reimbursement decisions

"A new study suggests that GLP-1 drugs, commonly used for diabetes and obesity, may slow cancer progression. The findings could influence treatment guidelines and reimbursement decisions relevant to Irish patients."